Literature DB >> 1699202

Site-directed mutagenesis of the conserved Asp-443 and Asp-498 carboxy-terminal residues of HIV-1 reverse transcriptase.

V Mizrahi1, M T Usdin, A Harington, L R Dudding.   

Abstract

Substitution of the conserved Asp-443 residue of HIV-1 reverse transcriptase by asparagine specifically suppressed the ribonuclease H activity of the enzyme without affecting the reverse transcriptase activity, suggesting involvement of this ionizable residue at the ribonuclease H active site. An analogous asparagine substitution of the Asp-498 residue yielded an unstable enzyme that was difficult to enzymatically characterize. However, the instability caused by the Asn-498 mutation was relieved by the introduction of a second distal Asn-443 substitution, yielding an enzyme with wild type reverse transcriptase activity, but lacking ribonuclease H activity.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1699202      PMCID: PMC332210          DOI: 10.1093/nar/18.18.5359

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  22 in total

1.  Domain structure of the Moloney murine leukemia virus reverse transcriptase: mutational analysis and separate expression of the DNA polymerase and RNase H activities.

Authors:  N Tanese; S P Goff
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

2.  Linker insertion mutagenesis of the human immunodeficiency virus reverse transcriptase expressed in bacteria: definition of the minimal polymerase domain.

Authors:  V R Prasad; S P Goff
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

Review 3.  Empirical predictions of protein conformation.

Authors:  P Y Chou; G D Fasman
Journal:  Annu Rev Biochem       Date:  1978       Impact factor: 23.643

4.  Mechanism of release of the avian rotavirus tRNATrp primer molecule from viral DNA by ribonuclease H during reverse transcription.

Authors:  C A Omer; A J Faras
Journal:  Cell       Date:  1982-10       Impact factor: 41.582

Review 5.  Enzyme-catalyzed phosphoryl transfer reactions.

Authors:  J R Knowles
Journal:  Annu Rev Biochem       Date:  1980       Impact factor: 23.643

6.  Mutational analysis of the ribonuclease H activity of human immunodeficiency virus 1 reverse transcriptase.

Authors:  A Hizi; S H Hughes; M Shaharabany
Journal:  Virology       Date:  1990-04       Impact factor: 3.616

7.  Endoribonucleolytic cleavage of RNA: oligodeoxynucleotide hybrids by the ribonuclease H activity of HIV-1 reverse transcriptase.

Authors:  L R Dudding; A Harington; V Mizrahi
Journal:  Biochem Biophys Res Commun       Date:  1990-02-28       Impact factor: 3.575

8.  Mechanism of RNA primer removal by the RNase H activity of avian myeloblastosis virus reverse transcriptase.

Authors:  J J Champoux; E Gilboa; D Baltimore
Journal:  J Virol       Date:  1984-03       Impact factor: 5.103

9.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

Review 10.  Oxygen chiral phosphate esters.

Authors:  J A Gerlt; J A Coderre; S Mehdi
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1983
View more
  18 in total

1.  Replication of phenotypically mixed human immunodeficiency virus type 1 virions containing catalytically active and catalytically inactive reverse transcriptase.

Authors:  J G Julias; A L Ferris; P L Boyer; S H Hughes
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

2.  Reverse transcriptase of human immunodeficiency virus type 1: functionality of subunits of the heterodimer in DNA synthesis.

Authors:  Z Hostomsky; Z Hostomska; T B Fu; J Taylor
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

3.  Cassette mutagenesis of the reverse transcriptase of human immunodeficiency virus type 1.

Authors:  P L Boyer; A L Ferris; S H Hughes
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

4.  Comparative analysis of immune responses induced by vaccination with SIV antigens by recombinant Ad5 vector or plasmid DNA in rhesus macaques.

Authors:  Lauren A Hirao; Ling Wu; Abhishek Satishchandran; Amir S Khan; Ruxandra Draghia-Akli; Adam C Finnefrock; Andrew J Bett; Michael R Betts; Danilo R Casimiro; Niranjan Y Sardesai; J Joseph Kim; John W Shiver; David B Weiner
Journal:  Mol Ther       Date:  2010-06-15       Impact factor: 11.454

5.  Asymmetric subunit organization of heterodimeric Rous sarcoma virus reverse transcriptase alphabeta: localization of the polymerase and RNase H active sites in the alpha subunit.

Authors:  S Werner; B M Wöhrl
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

6.  Deoxy- and dideoxynucleotide discrimination and identification of critical 5' nuclease domain residues of the DNA polymerase I from Mycobacterium tuberculosis.

Authors:  V Mizrahi; P Huberts
Journal:  Nucleic Acids Res       Date:  1996-12-15       Impact factor: 16.971

Review 7.  Targeting Metalloenzymes for Therapeutic Intervention.

Authors:  Allie Y Chen; Rebecca N Adamek; Benjamin L Dick; Cy V Credille; Christine N Morrison; Seth M Cohen
Journal:  Chem Rev       Date:  2018-09-07       Impact factor: 60.622

8.  Discontinuous plus-strand DNA synthesis in human immunodeficiency virus type 1-infected cells and in a partially reconstituted cell-free system.

Authors:  G J Klarmann; H Yu; X Chen; J P Dougherty; B D Preston
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

9.  Virion instability of human immunodeficiency virus type 1 reverse transcriptase (RT) mutated in the protease cleavage site between RT p51 and the RT RNase H domain.

Authors:  Michael E Abram; Michael A Parniak
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

10.  The ribonuclease activity of SAMHD1 is required for HIV-1 restriction.

Authors:  Jeongmin Ryoo; Jongsu Choi; Changhoon Oh; Sungchul Kim; Minji Seo; Seok-Young Kim; Daekwan Seo; Jongkyu Kim; Tommy E White; Alberto Brandariz-Nuñez; Felipe Diaz-Griffero; Cheol-Heui Yun; Joseph A Hollenbaugh; Baek Kim; Daehyun Baek; Kwangseog Ahn
Journal:  Nat Med       Date:  2014-07-20       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.